Advanced search×

Product development plan for new vaccine technologies.

Vaccine 19(13-14):1559-66 (2001) PMID 11166875

DOI: 10.1016/S0264-410X(00)00352-2
Version: za2963e q8zae q8zb9 q8zca q8zd2 q8ze8 q8zff q8zg8

Similar articles you may find interesting…

  1. Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine (HibMenCY-TT; MenHibrix(®)): A Review.

    Drugs (2013) PMID 23649970

    The meningococcal groups C and Y and Haemophilus b (Hib) tetanus toxoid conjugate vaccine (HibMenCY-TT) contains Neisseria meningitidis serogroup C and Y capsular polysaccharide antigens, and Hib capsular polysaccharide [polyribosyl-ribitol-phosphate (PRP)]. The HibMenCY-TT vaccine i...
  2. Cytoskeleton-Dependent Endomembrane Organization in Plant Cells: An Emerging Role for Microtubules.

    Plant J (2013) PMID 23647215

    We provide an overview of current knowledge on actin-mediated organelle movement within the secretory pathway of plant cells and report on recent and exciting findings that support a critical role of microtubules in plant cell development, in fine-tuning the positioning of Golgi stacks as well as th...
  3. Comparison of Gene Expression Profiles Between Pansensitive and Multidrug-Resistant Strains of Mycobacterium tuberculosis.

    Curr Microbiol (2013) PMID 23649743

    We compared the gene expression profiles between the pansensitive H37Rv strain and a clinical CIBIN:UMF:15:99 multidrug-resistant isolate using microarray analysis. Quantitative real-time PCR confirmed that in the clinical multidrug-resistant isolate, the esxG, esxH, rpsA, esxI, and rpmI genes were...